Steve Aselage, Director at Travere Therapeutics, Inc. (TVTX), sold 11,098 shares at $26.02 ($289K) on 2020-12-15, disclosed to the SEC on 2020-12-16.
Open-market sale of $289k TVTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.02 | 5,549 | $144K | 50.0% |
| 2 | $26.02 | 5,549 | $144K | 50.0% |
| Total | $26.02 avg | 11,098 | $289K | 100% |
| Filing → |
| TVTX | SELL | 2022-05-12 | $113K | — | Filing → |
| ACER | BUY | 2021-12-13 | $21K | — | Filing → |
| TVTX | SELL | 2021-11-18 | $935K | — | Filing → |